These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 17339439)

  • 1. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis.
    Mann MK; Maresz K; Shriver LP; Tan Y; Dittel BN
    J Immunol; 2007 Mar; 178(6):3447-56. PubMed ID: 17339439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
    Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.
    Matsushita T; Horikawa M; Iwata Y; Tedder TF
    J Immunol; 2010 Aug; 185(4):2240-52. PubMed ID: 20624940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis.
    Fernandez-Martin A; Gonzalez-Rey E; Chorny A; Ganea D; Delgado M
    Eur J Immunol; 2006 Feb; 36(2):318-26. PubMed ID: 16402407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis.
    Tauro S; Nguyen P; Li B; Geiger TL
    Eur J Immunol; 2013 May; 43(5):1195-207. PubMed ID: 23436224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand.
    Ray A; Basu S; Williams CB; Salzman NH; Dittel BN
    J Immunol; 2012 Apr; 188(7):3188-98. PubMed ID: 22368274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
    Fransson M; Piras E; Burman J; Nilsson B; Essand M; Lu B; Harris RA; Magnusson PU; Brittebo E; Loskog AS
    J Neuroinflammation; 2012 May; 9():112. PubMed ID: 22647574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis.
    Matsumoto Y; Sakuma H; Kohyama K; Park IK
    J Neuroimmunol; 2007 Jul; 187(1-2):44-54. PubMed ID: 17499858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
    Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity.
    Reinwald S; Wiethe C; Westendorf AM; Breloer M; Probst-Kepper M; Fleischer B; Steinkasserer A; Buer J; Hansen W
    J Immunol; 2008 May; 180(9):5890-7. PubMed ID: 18424708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB; Czerkinsky C; Holmgren J
    J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.
    Liu JQ; Liu Z; Zhang X; Shi Y; Talebian F; Carl JW; Yu C; Shi FD; Whitacre CC; Trgovcich J; Bai XF
    J Immunol; 2012 Apr; 188(7):3099-106. PubMed ID: 22387555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway.
    Chen X; Fang L; Song S; Guo TB; Liu A; Zhang JZ
    J Immunol; 2009 Nov; 183(10):6135-44. PubMed ID: 19841165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells.
    Subramanian S; Yates M; Vandenbark AA; Offner H
    Immunology; 2011 Mar; 132(3):340-7. PubMed ID: 21091909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
    Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
    Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
    Piccio L; Cantoni C; Henderson JG; Hawiger D; Ramsbottom M; Mikesell R; Ryu J; Hsieh CS; Cremasco V; Haynes W; Dong LQ; Chan L; Galimberti D; Cross AH
    Eur J Immunol; 2013 Aug; 43(8):2089-100. PubMed ID: 23640763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CD4⁺ Foxp3⁺ regulatory T cells proceeds normally in the absence of B cells during EAE.
    Hoehlig K; Shen P; Lampropoulou V; Roch T; Malissen B; O'Connor R; Ries S; Hilgenberg E; Anderton SM; Fillatreau S
    Eur J Immunol; 2012 May; 42(5):1164-73. PubMed ID: 22539290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
    J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms.
    Podojil JR; Liu LN; Marshall SA; Chiang MY; Goings GE; Chen L; Langermann S; Miller SD
    J Autoimmun; 2013 Aug; 44():71-81. PubMed ID: 23683881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.